NPM-ALK regulated activation of the AP-1 transcription factor in anaplastic large cell lymphomas (ALCL)

被引：0
|
作者：
不详
机构：
来源：
PATHOLOGY RESEARCH AND PRACTICE | 2005年 / 201卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
引用
收藏
页码：223 / 224
页数：2
相关论文
共 50 条
  • [21] The Tumor Suppressor SAMHD1 is a Novel Downstream Target of NPM-ALK Oncoprotein and MYC in Anaplastic Large Cell Lymphoma (ALCL)
    Tsesmetzis, Nikolaos
    Harold, Nikolas
    da Silva, Pedro Farrajota Neves
    Hanna, Daniela Kas
    Xagoraris, Ioanna
    Medeiros, L. Jeffrey
    Drakos, Elias
    Leventaki, Vasiliki
    Rassidakis, George Z.
    MODERN PATHOLOGY, 2019, 32
  • [22] The oncoprotein NPM-ALK induces translation of AP-1 factors via mTOR signalling
    Staber, P.
    Vesely, P.
    Fuchs, C.
    Bambach, I.
    Schauer, S.
    Bergler, H.
    Sternberg, D.
    Hoefler, G.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 344 - 344
  • [23] NPM-ALK-reactive T-cell responses in children and adolescents with NPM-ALK positive anaplastic large cell lymphoma
    Singh, Vijay Kumar
    Werner, Sebastian
    Schwalm, Simone
    Lennerz, Volker
    Ruf, Stephanie
    Stadler, Serena
    Hackstein, Holger
    Reiter, Alfred
    Woelfel, Thomas
    Damm-Welk, Christine
    Woessmann, Wilhelm
    ONCOIMMUNOLOGY, 2019, 8 (09):
  • [24] NPM-ALK Is a Key Regulator of the Oncoprotein FOXM1 in ALK-Positive Anaplastic Large Cell Lymphoma
    Haque, Moinul
    Li, Jing
    Huang, Yung-Hsing
    Almowaled, Meaad
    Barger, Carter J.
    Karpf, Adam R.
    Wang, Peng
    Chen, Will
    Turner, Suzanne D.
    Lai, Raymond
    CANCERS, 2019, 11 (08)
  • [25] The FOXO3a transcription factor is a target of cell survival and proliferative signaling by the NPM-ALK fusion kinase of anaplastic large cell lymphoma.
    Sternberg, DW
    Gu, TL
    Tothova, Z
    Scheijen, B
    Griffin, JD
    Gilliland, DG
    BLOOD, 2003, 102 (11) : 25A - 25A
  • [26] MKK4 and MKK7 Interact with NPM-ALK and Contribute to Tumor Cell Proliferation and Survival in NPM-ALK plus Anaplastic Large Cell Lymphoma
    Rassidakis, G.
    Georgoulis, P.
    Atsaves, V.
    Tsioli, P.
    Drakos, E.
    Medeiros, L. J.
    Panayiotidis, P.
    Patsouris, E.
    LABORATORY INVESTIGATION, 2010, 90 : 318A - 318A
  • [27] Abnormal AP-1 transcription factor protein expression in cutaneous large-cell lymphomas
    Mao, X.
    Orchard, G.
    BRITISH JOURNAL OF HAEMATOLOGY, 2007, 137 : 15 - 15
  • [28] NPM-ALK induces tumour development in a murine model of anaplastic large cell lymphoma (ALCL) independently of Bcl-3 expression
    Gruber, Charlotte
    Grundler, Rebekka
    Haecker, Georg
    Fend, Falco
    Peschel, Christian
    Duyster, Justus, III
    BLOOD, 2007, 110 (11) : 142A - 142A
  • [29] MKK4 and MKK7 Interact with NPM-ALK and Contribute to Tumor Cell Proliferation and Survival in NPM-ALK plus Anaplastic Large Cell Lymphoma
    Rassidakis, G.
    Georgoulis, P.
    Atsaves, V.
    Tsioli, P.
    Drakos, E.
    Medeiros, L. J.
    Panayiotidis, P.
    Patsouris, E.
    MODERN PATHOLOGY, 2010, 23 : 318A - 318A
  • [30] Sin1 is Upregulated by NPM-ALK and Contributes to Cell Cycle Progression and Survival in Anaplastic Large Cell Lymphoma
    Tsesmetzis, Nikolaos
    Baltatzis, George
    Chioureas, Dimitrios
    Leventaki, Vasiliki
    Drakos, Elias
    Panaretakis, Theocharis
    Rassidakis, George
    LABORATORY INVESTIGATION, 2016, 96 : 379A - 380A
12345